The investment concerns the development of advanced autologous therapies, with a budget of EUR 82 920 000. It includes industrial research, installation of a coordinating production unit in the Regional Unit of Corinthia, seven (7) mobile units at first in Athens (2) , Thessaloniki (1), Heraklion (1), Ioannina (1), Larissa (1) and Alexandroupolis (1), as well as experimental development and production of new treatments. It will create 174 new A.W.U. (Annual Work Units) by the end of its 6th year of operation and 512 A.W.U. by 2040.
